Related Experiment Video
Updated: Nov 16, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Chronic organ injuries in children with sickle cell disease
Slimane Allali1, Melissa Taylor2, Joséphine Brice3
1Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Assistance Publique - Hôpitaux de Paris (AP-HP), Université de Paris, Paris; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Université de Paris, Imagine Institute, Inserm U1163, Paris; Laboratory of Excellence GR-Ex.
Insights
Sickle cell disease patients face premature death from organ failure despite increased life expectancy. Early screening and interventions like transcranial Doppler can prevent strokes, but other organ damage monitoring needs further research.
Area of Science:
- Hematology
- Cardiology
- Nephrology
- Neurology
Background:
- Sickle cell disease (SCD) median life expectancy has improved to 55 years.
- Premature death in SCD patients often results from organ failure, including pulmonary hypertension, kidney injury, and cerebral vasculopathy.
- Organ damage in SCD can be asymptomatic and requires early, systematic screening.
Purpose of the Study:
- To review current screening and therapeutic strategies for organ damage in sickle cell disease.
- To identify prognostic indicators and effective interventions for SCD-related complications.
- To highlight areas requiring further research in SCD management.
Main Methods:
- Review of existing literature on screening protocols and therapeutic interventions for SCD organ damage.
- Analysis of diagnostic tools such as transcranial Doppler and echocardiography.
- Evaluation of biomarkers like albuminuria for kidney injury prediction.
Main Results:
- Transcranial Doppler screening combined with transfusions significantly reduces stroke risk.
- Increased albuminuria predicts kidney injury in SCD patients.
- Prognostic value of tricuspid regurgitant jet velocity in children is undetermined; screening for hip and eye disorders is recommended but lacks standardized strategies.
Conclusions:
- Systematic screening is crucial for early detection of asymptomatic organ damage in SCD.
- While stroke prevention is established, consensus on screening and therapy for silent cerebral infarcts is lacking.
- Further research is needed to confirm the benefits of hydroxyurea and evaluate new drugs for preventing chronic organ damage in SCD.
Abstract:
Median life expectancy of patients with sickle cell disease has increased to up to 55 years but there are still frequent cases of premature death, mostly in patients with pre-existing organ failure such as pulmonary hypertension, kidney injury, and cerebral vasculopathy. Most organ injuries remain asymptomatic for a long time and can only be detected through early systematic screening. Protocols combining assessment of velocities on transcranial Doppler and regular transfusions in patients with abnormal velocities have been demonstrated to dramatically reduce the risk of stroke. In contrast, no consensus has been reached on systematic screening or therapy for silent cerebral infarcts. The prognostic significance of increased tricuspid regurgitant jet velocity on echocardiography has not yet been identified in children, whereas increased albuminuria is a good predictor of kidney injury. Finally, screening for hip and eye disorder is recommended; however, different countries adopt different screening strategies. Hydroxyurea is probably of potential benefit in preventing chronic organ damage but this requires further study in order to be fully demonstrated. Efficacy and safety of the other new drugs available are also under investigation.
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
08:04A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
Published on: June 11, 2019
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention